The test will be accessible via healthcare professional referrals in Western Australia and the Northern Territory.

Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT ...

The proteoCHIP LF 48 is a state-of-the-art label-free single-cell proteomics sample preparation solution. Designed for ...

Proteomics International Laboratories’ PromarkerD blood test has proven to be a step up in predicting chronic kidney disease ...

Proteomics International Laboratories (ASX: PIQ) has officially launched its unique PromarkerD predictive test for diabetic ...

PORTLAND, IL, UNITED STATES, March 11, 2025 /EINPresswire / -- The proteomics market is witnessing significant growth propelled by advancements in technology, such as mass spectrometry and protein ...

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce the official laun ...

Proteomics International aptly has chosen World Kidney Day to launch its predictive test for diabetic kidney disease locally.

ACT Genomics expands its offerings by exclusively introducing mProbe's OncoOmicsDX, bridging genomics and proteomics for more ...

The global peptide microarray market share analysis is on a steady growth trajectory, projected to reach USD 903.8 million by 2025, with a compound annual growth rate (CAGR) of 3.8%. By 2035, the ...

Enabling well-powered studies, absolute quantification, and unlimited content flexibility. GEN spoke with Milad Dagher, PhD, CEO and co-founder of Nomic, about how their nELISA platform is ...